Sheryl L Conley is Director of Anika Therapeutics, Inc.. Currently has a direct ownership of 28,404 shares of ANIK, which is worth approximately $482,015. The most recent transaction as insider was on Jul 09, 2024, when has been sold 5,771 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.4K
0% 3M change
25.5% 12M change
Total Value Held $482,015

SHERYL L CONLEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 09 2024
BUY
Grant, award, or other acquisition
-
5,771 Added 16.89%
28,404 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
6,500 Added 22.31%
22,633 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
7,954 Added 33.02%
16,133 Common Stock
Oct 28 2021
BUY
Grant, award, or other acquisition
-
8,179 Added 50.0%
8,179 Common Stock

Also insider at

SRGA
SURGALIGN HOLDINGS, INC. Healthcare
STIM
Neuronetics, Inc. Healthcare
SLC

Sheryl L Conley

Director
Deerfield, IL

Track Institutional and Insider Activities on ANIK

Follow Anika Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIK shares.

Notify only if

Insider Trading

Get notified when an Anika Therapeutics, Inc. insider buys or sells ANIK shares.

Notify only if

News

Receive news related to Anika Therapeutics, Inc.

Track Activities on ANIK